Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
BMC Cancer|September 15, 2020
Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocolXiao Chang, Lei Deng, Wenjie Ni, et al.
Frontiers in Medicine|December 18, 2023
Sirolimus in combination with low-dose extended-release tacrolimus in kidney transplant recipientsZhi-Yu Zou, Lin-Rui Dai, Yi-Bo Hou, et al.
Journal of Advanced Research|April 24, 2025
A novel TGR5 agonist Sauchinone ameliorates IMQ induced murine psoriasis by regulating macrophage polarizationHao-Yu Wang, Su-Ling Huang, Jing Ren, et al.
Frontiers in Aging Neuroscience|September 8, 2022
Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson's diseaseChuan Ze Liu, Da Shuai Guo, Jian Jun Ma, et al.
Future Oncology (London, England)|January 5, 2024
Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocolLin-Rui Gao, Xinyue Wang, Changfa Xia, et al.
BMC Cancer|September 23, 2020
A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocolLin-Rui Gao, Xin Wang, Weiming Han, et al.
Therapeutic Advances in Medical Oncology|September 4, 2025
A nomogram for predicting the risk of chemoradiotherapy-associated thrombocytopenia in patients with esophageal cancer: a real-world cohort studyJia-Xuan Yang, Si-Yu Zuo, Jie Yang, et al.
Leukemia & Lymphoma|March 20, 2024
Treatment outcome, toxicity, and quality of life of patients with bronchus-associated lymphoid tissue lymphomaLin-Rui Gao, Xinyue Wang, Yunpeng Wu, et al.
Therapeutic Advances in Medical Oncology|August 4, 2022
Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapyLin-Rui Gao, Chen Li, Weiming Han, et al.
Pharmacological Research|July 15, 2023
CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8<sup>+</sup>Tim3<sup>+</sup> exhausted T cells in non-small cell lung cancerJian Wang, Run-Ze Li, Wen-Jun Wang, et al.
Pageof 13